NCT05627297View on ClinicalTrials.gov

Applying Artificial Intelligence to Optimize Early-stage Hepatocellular Carcinoma Treatment Based on Multi-modal Image

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2025

Conditions
Hepatocellular Carcinoma
Interventions
OTHER

CEUS and CEMRI

contrast-enhanced ultrasound and contrast-enhanced MRI examination

Trial Locations (1)

210009

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

All Listed Sponsors
lead

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER